Log in

CRH Medical Stock Forecast, Price & News

-0.06 (-2.83 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $2.06
50-Day Range N/A
52-Week Range
Now: $2.06
Volume21,826 shs
Average Volume114,445 shs
Market Capitalization$147.29 million
P/E RatioN/A
Dividend YieldN/A
CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Read More
CRH Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars

Industry, Sector and Symbol

Industry Medical Instruments & Supplies
Previous SymbolNYSEARCA:CRHM



Sales & Book Value

Annual SalesN/A



Market Cap$147.29 million
Next Earnings Date11/5/2020 (Estimated)
OptionableNot Optionable
-0.06 (-2.83 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRHM News and Ratings via Email

Sign-up to receive the latest news and ratings for CRHM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

CRH Medical (NYSEAMERICAN:CRHM) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of CRH Medical?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CRH Medical in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CRH Medical

When is CRH Medical's next earnings date?

CRH Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for CRH Medical

How were CRH Medical's earnings last quarter?

CRH Medical Corp (NYSEAMERICAN:CRHM) posted its quarterly earnings results on Monday, August, 10th. The company reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.04. The business earned $13.59 million during the quarter, compared to analysts' expectations of $6.50 million.
View CRH Medical's earnings history

What price target have analysts set for CRHM?

4 equities research analysts have issued 1 year price objectives for CRH Medical's shares. Their forecasts range from $3.50 to $4.50. On average, they anticipate CRH Medical's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 94.2% from the stock's current price.
View analysts' price targets for CRH Medical

Are investors shorting CRH Medical?

CRH Medical saw a increase in short interest in September. As of September 15th, there was short interest totaling 68,300 shares, an increase of 279.4% from the August 31st total of 18,000 shares. Based on an average daily trading volume, of 88,500 shares, the short-interest ratio is currently 0.8 days. Currently, 0.1% of the shares of the stock are sold short.
View CRH Medical's Short Interest

Who are some of CRH Medical's key competitors?

What other stocks do shareholders of CRH Medical own?

Who are CRH Medical's key executives?

CRH Medical's management team includes the following people:
  • Mr. Edward Wright, CEO & Non-Independent Director (Age 56)
  • Mr. Richard K. Bear, CFO & Corp. Sec. (Age 56)
  • Mr. James Kreger, Pres of CRH Anesthesia Management
  • Ms. Kettina Cordero, Director of Investor Relations

What is CRH Medical's stock symbol?

CRH Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CRHM."

Who are CRH Medical's major shareholders?

CRH Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Pacific Ridge Capital Partners LLC (4.34%), Stifel Financial Corp (2.92%), Parcion Private Wealth LLC (0.28%), CLARET ASSET MANAGEMENT Corp (0.26%), Seizert Capital Partners LLC (0.14%) and Ritholtz Wealth Management (0.04%). Company insiders that own CRH Medical stock include David Allan Johnson and James Kreger.
View institutional ownership trends for CRH Medical

Which institutional investors are selling CRH Medical stock?

CRHM stock was sold by a variety of institutional investors in the last quarter, including Parcion Private Wealth LLC.
View insider buying and selling activity for CRH Medical

Which institutional investors are buying CRH Medical stock?

CRHM stock was acquired by a variety of institutional investors in the last quarter, including Pacific Ridge Capital Partners LLC, Seizert Capital Partners LLC, Stifel Financial Corp, Ritholtz Wealth Management, and CLARET ASSET MANAGEMENT Corp.
View insider buying and selling activity for CRH Medical

How do I buy shares of CRH Medical?

Shares of CRHM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CRH Medical's stock price today?

One share of CRHM stock can currently be purchased for approximately $2.06.

How big of a company is CRH Medical?

CRH Medical has a market capitalization of $147.29 million. CRH Medical employs 112 workers across the globe.

What is CRH Medical's official website?

The official website for CRH Medical is investors.crhsystem.com.

How can I contact CRH Medical?

CRH Medical's mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company can be reached via phone at +1-604-6331440.

This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.